BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8152298)

  • 1. Analysis of the p53 gene in myeloid malignancies associated with chromosomal abnormalities involving the short arm of chromosome 17.
    Rege-Cambrin G; Gaidano G; Serra A; Scaravaglio P; Guglielmelli T; Guerrasio A; Giovinazzo B; Saglio G
    Leukemia; 1994 Apr; 8 Suppl 1():S23-6. PubMed ID: 8152298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p.
    Nakai H; Misawa S; Toguchida J; Yandell DW; Ishizaki K
    Cancer Res; 1992 Dec; 52(23):6588-93. PubMed ID: 1423304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic alterations in the p53 gene in the blast crisis of chronic myelogenous leukemia: analysis by polymerase chain reaction based techniques.
    Neubauer A; He M; Schmidt CA; Huhn D; Liu ET
    Leukemia; 1993 Apr; 7(4):593-600. PubMed ID: 8464238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations.
    Lai JL; Preudhomme C; Zandecki M; Flactif M; Vanrumbeke M; Lepelley P; Wattel E; Fenaux P
    Leukemia; 1995 Mar; 9(3):370-81. PubMed ID: 7885035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the p53 gene in patients with isochromosome 17q and Ph1-positive or -negative myeloid leukemia.
    Schütte J; Opalka B; Becher R; Bardenheuer W; Szymanski S; Lux A; Seeber S
    Leuk Res; 1993 Jun; 17(6):533-9. PubMed ID: 8505851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Abnormalities of chromosome 17 in myeloid malignancies with complex chromosomal abnormalities].
    Zhu Y; Xu W; Liu Q; Pan J; Qiu H; Wang R; Qiao C; Jiang Y; Zhang S; Fan L; Zhang J; Shen Y; Xue Y; Li J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):579-82. PubMed ID: 18841577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of tumor progression in chronic myeloproliferative disorders.
    Gaidano G; Guerrasio A; Serra A; Rege-Cambrin G; Saglio G
    Leukemia; 1994 Apr; 8 Suppl 1():S27-9. PubMed ID: 8152300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 in chronic myeloid leukemia cell lines.
    Bi S; Hughes T; Bungey J; Chase A; de Fabritiis P; Goldman JM
    Leukemia; 1992 Aug; 6(8):839-42. PubMed ID: 1640738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 gene mutations and loss of a chromosome 17p in Philadelphia chromosome (Ph1)-positive acute leukemia.
    Nakai H; Misawa S; Tanaka S; Nishigaki H; Taniwaki M; Yokota S; Horiike S; Takashima T; Seriu T; Nakagawa H
    Leukemia; 1993 Oct; 7(10):1547-51. PubMed ID: 8412316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
    Okabe M
    Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoallelic deletions of the P53 gene in Chinese patients with chronic myelogenous leukemia in blastic crisis.
    Chen SJ; Wang Q; Tong JH; Xie WJ; Cao Q; Cai JR; Li XS; Wang ZY; Chen Z; Larsen CJ
    Nouv Rev Fr Hematol (1978); 1991; 33(6):481-4. PubMed ID: 1818302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome 17 abnormalities and inactivation of the p53 gene in chronic myeloid leukemia and their prognostic significance.
    Nakai H; Misawa S
    Leuk Lymphoma; 1995 Oct; 19(3-4):213-21. PubMed ID: 8535212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of a variant Ph1 translocation t(9;22;11) (q34;q11;q13) in chronic myelogenous leukemia (CML) reveals the translocation of the 3'-part of BCR gene to the chromosome band 11q13.
    Koduru PR; Goh JC; Pergolizzi RG; Lichtman SM; Broome JD
    Oncogene; 1993 Dec; 8(12):3239-47. PubMed ID: 8247527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic myelocytic leukemia in accelerated phase with i(17) (q10) and loss of p53 gene. Case report.
    Salles MT; Cervantes G; Guarner J; Sobrevilla-Calvo P; García-Carranca A
    Arch Med Res; 1997; 28(2):293-6. PubMed ID: 9204625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isochromosome 17q in blast crisis of chronic myeloid leukemia and in other hematologic malignancies is the result of clustered breakpoints in 17p11 and is not associated with coding TP53 mutations.
    Fioretos T; Strömbeck B; Sandberg T; Johansson B; Billström R; Borg A; Nilsson PG; Van Den Berghe H; Hagemeijer A; Mitelman F; Höglund M
    Blood; 1999 Jul; 94(1):225-32. PubMed ID: 10381517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic alterations in the region of the p53 gene on human chromosome 17 in colorectal cancer].
    Kashkin KN; Fleĭshman EV; Chumakov PM; Perevoshchikov AG
    Genetika; 1998 Aug; 34(8):1049-55. PubMed ID: 9777351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 gene mutations with chromosome 17 abnormalities in chronic myelogenous leukemia blast crisis patients persist in long-term cell lines but may be acquired in acute myeloid leukemia cells in vitro.
    Sen S; Zhou H; Andersson BS; Cork A; Freireich EJ; Stass SA
    Cancer Genet Cytogenet; 1995 Jul; 82(1):35-40. PubMed ID: 7627932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of amplified BCR/ABL fusion genes into the short arm of chromosome 17 as a novel mechanism of disease progression in chronic myeloid leukemia.
    Metzke-Heidemann S; Harder L; Gesk S; Schoch R; Jenisch S; Grote W; Siebert R; Schlegelberger B
    Genes Chromosomes Cancer; 2001 May; 31(1):10-4. PubMed ID: 11284030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelomonocytic crisis with t(5;17) and a p53 mutation in a patient with chronic myelogenous leukemia.
    Nakagawa H; Fujii H; Nakai H; Inazawa J; Misawa S
    Am J Hematol; 1994 Apr; 45(4):335-40. PubMed ID: 8178805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. dic(5;17): a recurring abnormality in malignant myeloid disorders associated with mutations of TP53.
    Wang P; Spielberger RT; Thangavelu M; Zhao N; Davis EM; Iannantuoni K; Larson RA; Le Beau MM
    Genes Chromosomes Cancer; 1997 Nov; 20(3):282-91. PubMed ID: 9365836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.